80
Participants
Start Date
March 23, 2018
Primary Completion Date
December 20, 2022
Study Completion Date
January 6, 2023
Normal Saline along with standard treatment
PMZ-1620 (sovateltide) is an endothelin-B receptor agonist. PMZ-1620 has the potential to be a first-in-class neuronal progenitor cell therapeutics that is likely to promote quicker recovery and improve neurological outcome in Alzheimer's disease patients. In this arm normal saline along with standard treatment will be given for active comparison.
PMZ-1620 (sovateltide) along with standard treatment
PMZ-1620 (sovateltide) is an endothelin-B receptor agonist. PMZ-1620 has the potential to be a first-in-class neuronal progenitor cell therapeutics that is likely to promote quicker recovery and improve neurological outcome in Alzheimer's disease patients.
All India Institute of Medical Sciences, New Delhi
Post Graduate Institute of Medical Education and Research, Chandigarh
King George's Medical University, Lucknow
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow
Seth GSMC & KEM Hospital, Mumbai
Lead Sponsor
Pharmazz, Inc.
INDUSTRY